Production (Stage)
CYduct Diagnostics, Inc.
CYDX
$0.2031
$0.0010.50%
OTC PK
| 03/31/2012 | 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | |
|---|---|---|---|---|---|
| Net Income | 109.72% | 57.75% | 54.61% | 45.24% | 42.26% |
| Total Depreciation and Amortization | -71.43% | -57.60% | -45.34% | -31.03% | -23.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.00% | -59.98% | -47.99% | -45.19% | -48.15% |
| Change in Net Operating Assets | -219.25% | -29.61% | 742.18% | 149.65% | 4,360.78% |
| Cash from Operations | -275.47% | 77.52% | 89.16% | 89.49% | 93.78% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | 353.33% | 223.64% | 353.33% |
| Total Debt Repaid | -330.00% | -24,000.00% | -49.38% | 187.01% | 181.25% |
| Issuance of Common Stock | 368.13% | -60.05% | -91.34% | -94.39% | -94.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 220.51% | -72.48% | -87.91% | -89.90% | -92.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.00% | 95.58% | 113.33% | 88.28% | 2,566.67% |